|  | 市场调查报告书 商品编码 1828048 2025年低温恒温器全球市场报告Cryostat Global Market Report 2025 | ||||||
近年来,低温恒温器市场稳定成长,预计2024年将达25.6亿美元,2025年将达26.8亿美元,复合年增长率为4.7%。预测期内的增长可归因于生物医学研究的扩展、低温电子显微镜(cryo-EM)的兴起、生物样本库和生物检体资料库的发展、癌症研究和诊断、药物研发、组织工程的进步以及人体冷冻服务的兴起。
预计未来几年低温恒温器市场规模将强劲成长,2029年将达36.1亿美元,复合年增长率为7.7%。预测期内的成长归因于诸多因素,例如其在製药製造业中的作用日益增强、基因组学研究的重要性日益提升、生物样本库活动的全球扩张、药品品管、向照护现场诊断的转变以及低温储存系统的进步。预测期内的主要趋势包括低温技术的进步、成像技术的创新、与人工智慧的融合、研发合作以及奈米技术的应用。
低温低温恒温器是医疗设备,用于将组织切片保持在恆定的低温下,将其切成薄片进行显微镜检查,并有助于诊断各种疾病和病症。它有助于保存冷冻的组织样本。
低温恒温器的主要类型包括闭循环低温恒温器、连续流低温恒温器、恆温槽低温恒温器和多级低温恒温器。封闭式循环低温恒温器是一种无氦系统,无需使用传统致冷剂即可冷却至液态氦温度。系统组件包括杜瓦瓶、转移管、气流泵、温度控制器、高真空帮浦和微调叶片,并使用多种致冷剂,包括氦气和氮气。低温恒温器广泛应用于医疗保健、能源电力、航空、冶金、生物技术、法医学和海洋生物学等多个产业。
2025年春季,美国关税飙升及其引发的贸易摩擦医疗设备产业产生了重大影响,尤其对影像处理设备、手术用不銹钢和一次性塑胶等进口零件产生了重大影响。由于医院和诊所抵制涨价,製造商面临利润压力。监管挑战进一步加剧了情况的复杂化,因为由于关税而更换供应商通常需要医疗设备重新认证,导致市场准入延迟。为此,企业正在透过双重采购关键零件、增加标准产品的国内生产以及加快研发更具成本效益的材料来降低风险。
本研究报告是商业研究公司(The Business Research Company)最新发布的低温恒温器器光学市场统计数据报告之一,涵盖低温恒温器低温恒温器器光学行业的全球市场规模、各地区市场份额、竞争对手的市场份额、详细的低温恒温器光学细分市场、市场趋势和商业机会,以及在低温恒温器恆温器光学行业取得成功所需的数据。低温恒温器光学市场研究报告对该行业的现状和未来趋势进行了详细分析,为您提供全面的观点。
未来五年7.7%的预测成长率,较我们先前对该市场的预测略有下降0.2%。下降主要源自于美国与其他国家之间关税的影响。这一影响将直接影响美国,导致来自义大利和英国等主要地区的切片机刀片组件和精密温控模组供应链中断,可能导致病理诊断延迟和组织学实验室成本增加。此外,由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响,这项影响也将更加广泛。
预计神经肌肉疾病盛行率的不断上升将推动未来低温恒温器市场的成长。神经肌肉疾病包括影响週边神经系统的疾病,通常导致进行性肌肉无力这种显着症状。这些疾病盛行率的不断上升推动了对低温恒温器的需求,因为低温恒温器在快速诊断各种疾病(包括神经肌肉疾病)中发挥关键作用。例如,2022 年 12 月,专注于肌肉骨骼损伤预防培训和咨询的英国公司 Osteopaths For Industry Ltd. 报告称,2021 年至 2022 年期间有 477,000 例与工作相关的肌肉骨骼疾病病例。此外,2022 年 7 月,世界卫生组织 (WHO) 指出,全球约有 17.1 亿人患有肌肉骨骼疾病。因此,神经肌肉疾病盛行率的不断上升正在推动低温恒温器市场的成长。
感染疾病的激增是低温恒温器市场崛起的主要原因。由病毒、细菌、真菌和寄生虫等各种病原体引起的感染疾病正变得越来越普遍。由于处理此类病原体存在潜在风险,因此在感染疾病管理中使用低温恒温器至关重要。组织检体通常含有传染性物质,需要特别处理,尤其是某些疾病检体呈阳性的个体的样本。例如,根据英国国家统计局的统计数据,截至 2022 年 12 月 9 日当週,感染率呈上升趋势,35 至 69 岁人口的感染率达到 1.92%,12 至 24 岁学龄人口的感染率达到 1.25%。因此,感染疾病的传播预计将推动低温恒温器市场的扩张。
低温恒温器市场的主要企业正在开发创新产品,例如氦回收解决方案,旨在提高永续性、降低营运成本并提高低温系统的效率。氦回收解决方案是专门设计用于回收、再循环和再利用氦气的系统,氦气是一种广泛用于低温恒温器等低温应用的宝贵且有限的资源。例如,2024 年 4 月,英国低温测量系统製造商 Bluefors 推出了 Cryomech HeRL02-RM。这种专门的氦回收解决方案针对单一核磁共振 (NMR) 系统。 HeRL02-RM 建立了一个闭合迴路系统,可从 NMR 磁铁中回收沸腾的氦气,将其透过蒸汽回流管线引导至脉管低温冷冻机驱动的液化器,在那里氦气被迅速液化并返回到磁铁的氦浴中。
低温恒温器市场的主要参与企业正在推进零沸腾 (ZBO) 等技术,以最大限度地减少低温流体损失、提高系统效率并降低维护成本。 ZBO 技术可防止液态氦和液态氮等低温流体的蒸发和损失,这些流体容易因温度变化而沸腾。例如,2023 年 4 月,印度低温工程公司 INOXCVA 成功製造了印度首台自主设计的 4K 氦低温低温恒温器,用于全身 1.5T超导性MRI 磁体系统。此低温恒温器采用零沸腾技术,显着减少了运作过程中的氦气损失,提高了效率和成本效益。
2022年8月,总部位于瑞典的跨国工业公司阿特拉斯·科普柯完成了对蒙大拿仪器公司的收购,具体金额未披露。此次策略性收购预计将显着拓展阿特拉斯科普柯在低温领域的现有业务,并加强其与研发客户的关係。此外,此次收购也为阿特拉斯·科普柯进入新兴量子技术相关市场提供了新的途径,这些市场的商业应用正逐渐普及。蒙大拿仪器公司以其在低温恒温器製造领域的专业知识而闻名,透过此次收购,该公司已成为阿特拉斯科普柯投资组合的一部分。
低温恒温器市场包括单压缩机、双压缩机、旋转式低温恒温器和电动低温恒温器的销售。该市场的价值指的是“出厂价”,即商品製造商或生产商销售给其他营业单位(包括下游製造商、批发商、经销商和零售商)或直接销售给最终客户的商品价值。该市场的商品价值还包括商品製造商销售的任何相关服务。低温恒温器市场细分为单压缩机、双压缩机、旋转式低温恒温器和其他低温恒温器。
A cryostat is a medical equipment designed to maintain tissue sections at a constant low temperature and slice them into thin sections for microscopic examination, facilitating the diagnosis of various diseases and ailments. It is instrumental in preserving frozen tissue samples.
The major types of cryostats include closed-cycle cryostats, continuous-flow cryostats, bath cryostats, and multistage cryostats. Closed-cycle cryostats are helium-free systems that enable cooling down to liquid helium temperatures without the use of traditional cryogens. The components of the system include dewars, transfer tubes, gas flow pumps, temperature controllers, high vacuum pumps, and microtone blades, with various cryogens such as helium and nitrogen. Cryostats find applications in various industries, including healthcare, energy and power, aeronautics, metallurgy, biotechnology, forensic science, and marine biology.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The cryostats market research report is one of a series of new reports from The Business Research Company that provides cryostats optical components market statistics, including cryostats optical components industry global market size, regional shares, competitors with a cryostats optical components market share, detailed cryostats optical components market segments, market trends and opportunities, and any further data you may need to thrive in the cryostats optical components industry. The cryostats optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cryostat market size has grown steadily in recent years. It will grow from $2.56 billion in 2024 to $2.68 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to expansion of biomedical research, rise of cryo-electron microscopy (cryo-EM), biobanking and biorepository development, cancer research and diagnostics, drug discovery and development, tissue engineering advancements, increase in cryonics services.
The cryostat market size is expected to see strong growth in the next few years. It will grow to $3.61 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to expanding role in drug manufacturing, growing importance of genomic research, global expansion of biobanking activities, quality control in pharmaceuticals, shift towards point-of-care diagnostics, advancements in cryogenic storage systems. Major trends in the forecast period include advancements in cryogenic technologies, technological innovations in imaging, integration with artificial intelligence, collaborations for research and development, applications in nanotechnology.
The forecast of 7.7% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for microtome blade assemblies and precision temperature control modules, sourced from key regions such as Italy and the UK, which could lead to delayed pathology diagnoses and increased histology laboratory costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of neuromuscular diseases is projected to drive growth in the cryostat market in the future. Neuromuscular diseases encompass conditions that affect the peripheral nervous system, often leading to progressive muscle weakness as a significant symptom. Cryostats play a crucial role in providing rapid diagnoses for various illnesses, including neuromuscular disorders, thus elevating the demand for cryostats in response to the rising incidence of these diseases. For instance, in December 2022, Osteopaths For Industry Ltd., a UK-based company focused on musculoskeletal injury prevention training and consultancy, reported 477,000 cases of work-related musculoskeletal disorders for the 2021-2022 period. Moreover, in July 2022, the World Health Organization indicated that approximately 1.71 billion people globally suffer from musculoskeletal disorders. Consequently, the increasing prevalence of neuromuscular diseases is driving the growth of the cryostat market.
The upsurge in infectious diseases is significantly contributing to the upward trajectory of the cryostat market. Infectious diseases, stemming from various pathogens such as viruses, bacteria, fungi, or parasites, are increasingly common. The utilization of cryostats in managing infectious diseases is crucial due to the potential risks associated with handling such agents. Tissue samples often contain infectious agents, necessitating specialized handling, particularly for samples from individuals positive for certain diseases. For instance, statistics from the Office for National Statistics in the UK indicated an escalating infection rate by the week ending December 9, 2022, notably reaching 1.92% among individuals aged 35 to 69 years and 1.25% in school years 12 to 24. Hence, the mounting prevalence of infectious diseases is anticipated to fuel the expansion of the cryostat market.
Leading companies in the cryostat market are developing innovative products, such as helium recovery solutions, aimed at enhancing sustainability, lowering operational costs, and improving the efficiency of cryogenic systems. Helium recovery solutions are systems specifically designed to capture, recycle, and reuse helium, a precious and limited resource widely used in cryogenic applications like cryostats. For example, in April 2024, Bluefors, a UK-based manufacturer of cryogenic measurement systems, launched the Cryomech HeRL02-RM. This specialized helium recovery solution is intended for single Nuclear Magnetic Resonance (NMR) systems. The HeRL02-RM establishes a closed-loop system that captures boiled-off helium from NMR magnets, redirecting it through a vapor return line to a Pulse Tube Cryocooler-powered liquefier, where it is rapidly liquefied and returned to the magnet's helium bath.
Key players in the cryostat market are advancing technologies like zero-boil-off (ZBO) technology to minimize the loss of cryogenic fluids, enhance system efficiency, and lower maintenance costs. ZBO technology is designed to prevent the evaporation or loss of cryogenic fluids, such as liquid helium or liquid nitrogen, which tend to boil off due to temperature variations. For instance, in April 2023, INOXCVA, an India-based cryogenic engineering company, successfully manufactured India's first indigenously designed 4K helium cryostat for a whole-body 1.5T superconducting MRI magnet system. This cryostat incorporates zero-boil-off technology, significantly reducing helium loss during operation, thus making it more efficient and cost-effective.
In August 2022, Atlas Copco, a multinational industrial company based in Sweden, completed the acquisition of Montana Instruments Corporation for an undisclosed sum. This strategic acquisition is expected to significantly expand Atlas Copco's existing footprint in the cryogenic markets and strengthen its relationships with research and development customers. Moreover, it provides an additional avenue for Atlas Copco to penetrate emerging quantum technology-related markets, where commercial applications are progressively gaining traction. Montana Instruments Corporation, renowned for its expertise in cryostat manufacturing, became a part of Atlas Copco's portfolio through this acquisition.
Major companies operating in the cryostat market include Lake Shore Cryotronics Inc, Cryomech Inc, Epredia, Hacker Instruments & Industries Inc, Histo-Line Laboratories Srl, Jinhua YIDI Medical Appliance Co Ltd, SLEE Medical GmbH, Leica Biosystems, Lupetec Technologies, MEDITE Medical GmbH, Boeckeler Instruments Inc, Bright Instruments Ltd, Precision Cryogenics Systems Inc, Atico Medical Pvt Ltd, Biobase Biodusty Co Ltd, Cryofab Inc., Amos Scientific, Thermo Fisher Scientific Inc., Oxford Instruments, Star Cryoelectronics, Infrared laboratories, Attocube Systems, Montana Instruments, Quantum Design, ICE Oxford, Cryogenic Limited, Bluefors, Cryoquip, CryoMAgnetics, Vacree Technologies
North America was the largest region in the cryostat market in 2024. Asia-Pacific is expected to be the fastest-growing region in the cryostat market during the forecast period. The regions covered in the cryostat market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the cryostat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cryostat market consists of sales of single compressor, double compressor, rotary cryostat, and motorized cryostat. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The cryostat market is segmented into single compressor, double compressor, rotary cryostat and other cryostats.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cryostat Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cryostat market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cryostat ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cryostat market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
